Tiziana Life Sciences Ltd Sustainability Reports

Tiziana Life Sciences Ltd. develops and commercializes innovative therapeutics for immune and inflammatory diseases as a publicly traded biotechnology company.

Sector: Health Care

Country: United Kingdom

Exchange: Nasdaq Stock Market

ISIN: BMG889121031

6 reports from 2014 to 2024

Company Profile

Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd. develops and commercializes innovative therapeutics for immune and inflammatory diseases as a publicly traded biotechnology company.

Reports

Available reports